Liposome-based drug delivery in breast cancer treatment (Q24802484)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Liposome-based drug delivery in breast cancer treatment	scientific article

Statements

instance of

scholarly article

0 references

review article

1 reference

stated in

PubMed

retrieved

14 September 2020

title

Liposome-based drug delivery in breast cancer treatment (English)

0 references

main subject

drug delivery

1 reference

based on heuristic

inferred from title

breast neoplasm

1 reference

stated in

PubMed

retrieved

14 September 2020

antineoplastic

1 reference

stated in

PubMed

retrieved

14 September 2020

breast cancer

1 reference

based on heuristic

inferred from title

author name string

John W Park

series ordinal

1

0 references

language of work or name

English

0 references

publication date

18 April 2002

4 references

stated in

PubMed Central

retrieved

13 March 2019

stated in

PubMed Central

retrieved

3 April 2019

stated in

PubMed Central

retrieved

17 June 2019

stated in

PubMed Central

retrieved

14 September 2020

published in

Breast Cancer Research

4 references

stated in

PubMed Central

retrieved

13 March 2019

stated in

PubMed Central

retrieved

3 April 2019

stated in

PubMed Central

retrieved

17 June 2019

stated in

PubMed Central

retrieved

14 September 2020

volume

4

0 references

issue

3

0 references

page(s)

95-9

0 references

cites work

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

7 April 2017

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

7 April 2017

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

7 April 2017

Tumor targeting using anti-her2 immunoliposomes.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 September 2017

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 September 2017

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 September 2017

Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 September 2017

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 September 2017

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 September 2017

Development of anti-p185HER2 immunoliposomes for cancer therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 September 2017

Immunoliposomes for Cancer Treatment

2 references

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

30 May 2018

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2FBCR432

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Developing drugs to decrease the toxicity of chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2FBCR432

retrieved

21 January 2018

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2FBCR432

retrieved

21 January 2018

Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2FBCR432

retrieved

21 January 2018

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2FBCR432

retrieved

21 January 2018

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 November 2018

Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138729

retrieved

28 November 2018

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2FBCR432

retrieved

21 January 2018

A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12052251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12052251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12052251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12052251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/BCR432

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

995372

Dimensions Publication ID

1033049162

0 references

OpenCitations bibliographic resource ID

995372

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

995372

PMC publication ID

138729

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

995372

PubMed publication ID

12052251

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

995372

ResearchGate publication ID

11321952

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24802484&oldid=2175255523"